Multiproduct Resin Reuse for Clinical and Commercial Manufacturing—Methodology and Acceptance Criteria

Reference

1. 1.↵
   1. Sharnez R.,
   2. Lathia J.,
   3. Kahlenberg D.,
   4. Prabhu S.,
   5. Dekleva M.

   In Situ Monitoring of Soil Dissolution Dynamics: A Rapid and Simple Method for Determining Worst-Case Soils for Cleaning Validation. PDA J. Pharm. Sci. Technol. 2004, 58 (4), 203–214.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Canhoto A.

   A Novel Bench Scale Apparatus to Model and Develop Biopharmaceutical Cleaning Procedures. Journal of Validation Technology, 2004, 11 (4).
3. 3.↵
   1. Sharnez R.,
   2. To A.,
   3. Tholudur A.

   Experimental Parameters for Cleaning Characterization; Part I: Dilution of Process Fluids during Cleaning. Journal of Validation Technology, 2013, 19 (3).
4. 4.↵
   1. Sharnez R.,
   2. To A.,
   3. Annapragada R.

   Experimental Parameters for Cleaning Characterization; Part II: Effect of Fluid Velocity on the Kinetics of Cleaning. Journal of Validation Technology, 2015, 21 (1).
5. 5.↵
   1. Pluta P.

   Laboratory Studies in Cleaning Validation. Journal of Validation Technology, 2007, 13 (4).
6. 6.↵
   1. Verghse G.,
   2. Kaiser N.

   Cleaning Agents and Cleaning Chemistry. Cleaning and Cleaning Validation; Davis Healthcare International & PDA, 2009; Vol. 1, Chapter 7.
7. 7.↵
   1. Verghese G.,
   2. Thomas J.

   Cleaning Agents for Biopharmaceutical Manufacturing. Genetic Engineering News, 2003, 23 (6).
8. 8.↵
   1. Sharnez R.,
   2. Klewer L.

   Strategies for Developing a Robust Cleaning Process—Part II: Demonstrating Cycle Effectiveness, American Pharmaceutical Review—Digital Edition, 2012, 15 (3).
9. 9.↵
   1. Sharnez R.,
   2. VanTrieste M.

   Quality-by-Design for Cleaning Validation. Cleaning and Cleaning Validation; Davis Healthcare International & PDA, 2009; Vol. 1, Chapter 6.
10. 10.↵
    1. Sharnez R.

    Master Soils for Cleaning Cycle Development and Validation: A Case Study, Cleaning and Cleaning Validation; Davis Healthcare International & PDA, 2012; Vol. 2, Chapter 9, pp 191-200.

    OpenUrl
11. 11.↵
    1. Sharnez R.

    Leveraging Small-Scale Models to Streamline Validation. Journal of Validation Technology, 2008, 14 (4).
12. 12.↵
    1. Hale G.,
    2. Drumm A.,
    3. Harrison P.,
    4. Phillips J.

    Repeated Cleaning of Protein A Affinity Column with Sodium Hydroxide. Journal of Immunological Methods, 1994, 171 (1), 15–21.

    OpenUrlPubMed
13. 13.↵
    1. Mahajan E.,
    2. Werber J.,
    3. Kothary K.,
    4. Larson T.

    One Resin, Multiple Products: A Green Approach to Purification. Developments in Biotechnology and Bioprocessing, ACS Symposium Series, 2013; Vol. 1125, Chapter 6, pp 87-111.

    OpenUrl
14. 14.↵
    1. Sharnez R.,
    2. To A.

    Strategies for Setting Rational MAC-based Limits—Part III: Leveraging Toxicology and Cleanability Data. Journal of Validation Technology, 2011, 17 (3), 24–28.

    OpenUrl
15. 15.↵
    1. Sharnez R.,
    2. Bussiere J.,
    3. Mytych D.,
    4. Spencer A.,
    5. To A.,
    6. Tholudur A.

    Acceptance Limits for Inactivated Product Based on Gelatin as a Reference Impurity. Journal of Validation Technology, 2013, 19 (1).
16. 16.↵
    1. Sharnez R.,
    2. et al

    . Methodology for Assessing Product Inactivation During Cleaning. Journal of Validation Technology, 2012, 18 (4), 42–45.

    OpenUrl
17. 17.↵
    1. Kendrick K.,
    2. Canhoto A.,
    3. Kreuze M.

    Analysis of Degradation Properties of Biopharmaceutical Active Ingredients as Caused by Various Process Cleaning Agents and Temperature. Journal of Validation Technology, 2009, 15 (3), 69.

    OpenUrl
18. 18.↵
    International Society for Pharmaceutical Engineers: Tampa, Florida. Risk-Based Manufacture of Pharmaceutical Products: A Guide to Managing Risks Associated with Cross-Contamination, 2nd ed.; 2017.
19. 19.↵
    1. Fourman G. L.,
    2. Mullen M. V.

    Determining Cleaning Validation Acceptance Limits for Pharmaceutical Manufacturing Operations. Pharmaceutical Technology, 1993, 17 (4), 54–60.

    OpenUrl
20. 20.↵
    1. Sharnez R.

    Unpublished work.
21. 21.↵
    1. Sharnez R.,
    2. To A.,
    3. Klewer L.

    Strategies for Setting Rational MAC-based Limits—Part II: Application to Rinse Samples. Journal of Validation Technology, 2011, 17 (2), 43–46.

    OpenUrl